<DOC>
	<DOCNO>NCT01950494</DOCNO>
	<brief_summary>Hand dermatitis , ( rash , eczema , hand ) common skin condition affect approximately 10 % population . It cause wide variety thing , allergens irritant . For , painful disfiguring . In moderate severe case , hand dermatitis interfere greatly quality life affect person , interfere work social function . This negative psychological effect well . FiteBac Skin Care Gel new over-the-counter hand sanitizer use hospital dental hand infection control . This product contain germicide , prevent infection . It also contain silicone polymer . This make hand gel durable , cause remain skin longer . Despite durability , hand gel still allow skin naturally perspire ( sweat ) . As people health-care industry use new product goal reduce hand infection , note FiteBac Skin Care Gel also seem reduced hand dermatitis improve personal skin condition . The purpose study scientifically measure skin improvement population study subject hand dermatitis .</brief_summary>
	<brief_title>FiteBac Hand Sanitizer Management Hand Dermatitis Adults</brief_title>
	<detailed_description>1 . Informed consent must sign understood subject . 2 . Symptoms history consistent hand dermatitis base symptom clinical history ( describe refs 4-7 ) . 3 . Males female , 18-70 year age , generally good health significant underlying systemic disease require ongoing medication . 4 . Hand eczema severity index ( HECSI ) score great 50 ( see Table 1 reference 5 ) 5 . Physician global assessment ( PGA ) moderate severe ( PGA severity score grade Table 1 reference 8 : severe , moderate , mild , almost clear , clear ) . 3.2.3 . Exclusion criterion 1 . Topical corticosteroid calcineurin inhibitor treatment last 7 day , prior enrollment , hand forearm 2 . Systemic treatment corticosteroid immunosuppressive last 14 day . 3 . Subjects currently receive ( receive previous 4 week ) investigational drug , treatment device , participate another clinical study . 4 . Treatment ultraviolet ( UV ) light ( include tan ) previous 4 week . 5 . Acute dermatitis outbreak arm hand . 6 . Subjects unable comply protocol restriction 7 . Subjects know unreliable non-compliant medical treatment , unwilling comply multiple return visit . 8 . Any condition prior/present treatment , opinion investigator , render patient ineligible study 9 . Known allergy benzalkonium chloride ingredient fiteBac vehicle</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Hand Sanitizers</mesh_term>
	<mesh_term>Emollients</mesh_term>
	<criteria>1 . Males female , 1870 year age , generally good health significant underlying systemic disease require ongoing medication . 2 . Hand eczema severity index ( HECSI ) score great 50 ( see Table 1 reference 5 ) 3 . Physician global assessment ( PGA ) moderate severe ( PGA severity score grade Table 1 reference 8 : severe , moderate , mild , almost clear , clear ) . 1 . Topical corticosteroid calcineurin inhibitor treatment last 7 day , prior enrollment , hand forearm 2 . Systemic treatment corticosteroid immunosuppressive last 14 day . 3 . Subjects currently receive ( receive previous 4 week ) investigational drug , treatment device , participate another clinical study . 4 . Treatment ultraviolet ( UV ) light ( include tan ) previous 4 week . 5 . Acute dermatitis outbreak arm hand . 6 . Subjects unable comply protocol restriction 7 . Subjects know unreliable noncompliant medical treatment , unwilling comply multiple return visit . 8 . Any condition prior/present treatment , opinion investigator , render patient ineligible study 9 . Known allergy benzalkonium chloride ingredient fiteBac vehicle</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>hand dermatitis</keyword>
	<keyword>health care worker</keyword>
	<keyword>hand sanitizer</keyword>
</DOC>